Neoadjuvant Immunotherapy for Locally Advanced Melanoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11864-020-0700-z.pdf
Reference38 articles.
1. Larkin J, Chiarion-Sileni V, Gonzalez R, Grob J-J, Rutkowski P, Lao CD, et al. Five-year survival with combined Nivolumab and Ipilimumab in advanced melanoma. N Engl J Med. 2019. https://doi.org/10.1056/NEJMoa1910836.
2. Schachter J, Ribas A, Long GV, Arance A, Grob JJ, Mortier L, et al. Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006). Lancet (London, England). 2017;390(10105):1853–62. https://doi.org/10.1016/s0140-6736(17)31601-x.
3. Hamid O, Robert C, Daud A, Hodi FS, Hwu WJ, Kefford R, et al. Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001. Annals of oncology : official journal of the European Society for Medical Oncology. 2019;30(4):582–8. https://doi.org/10.1093/annonc/mdz011.
4. Gershenwald JE, Scolyer RA. Melanoma staging: American joint committee on Cancer (AJCC) 8th edition and beyond. Ann Surg Oncol. 2018;25(8):2105–10. https://doi.org/10.1245/s10434-018-6513-7.
5. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American joint committee on Cancer melanoma staging system. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001;19(16):3622–34. https://doi.org/10.1200/jco.2001.19.16.3622.
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Anti‐PD‐(L)1‐Based Neoadjuvant Therapy in Head and Neck Carcinoma: a Meta‐analysis of Prospective Clinical Trials;Otolaryngology–Head and Neck Surgery;2024-06-29
2. Novel Macrophage Subtype Genes for Predicting Prognosis and Immunotherapy Response in Melanoma Based on Single-Cell and Bulk RNA Sequencing Analysis;2024-06-10
3. Neoadjuvant treatment for stage III and IV cutaneous melanoma;Cochrane Database of Systematic Reviews;2023-01-17
4. Melanoma;Oncologic Imaging : a Multidisciplinary Approach;2023
5. Neoadjuvant Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer;Journal of the College of Physicians and Surgeons Pakistan;2022-06-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3